They are used to replace, repair, or stimulate bone formation in various clinical settings—trauma, bone loss, orthopedic, dental, and maxillofacial surgeries.

   Among these innovations, Altis OBM (Osteogenic Bone Matrix), developed by Altis Biologics, stands out as an injectable bone substitute of natural origin, designed to actively induce bone formation. It contains bone morphogenetic proteins (BMPs) and TGF-β1, extracted from human bone matrix and purified using chromatography. This unique formulation offers excellent osteoinductive properties, facilitating bone healing without the need for autologous grafting.µ

Clinical Indications:

• Complex fractures and non-unions
• Maxillofacial reconstruction
• Spinal fusion
• Peri-implant bone defects in dental surgery
• Bone regeneration in osteoporotic conditions.

Other Innovations by Altis Biologics: 



Altis Biologics offers a comprehensive range of solutions tailored to various specialties:

Altis OBM – Maxillofacial / Periodontal / Trauma: specific formulations for targeted applications

Altis DBMXtra: enriched with bioactive components for focused regeneration

AltiCERAM: biomimetic ceramic for structured bone replacement

AltiMEM: collagen membrane for guided tissue regeneration

AltiGRAFT and AltiCOLL: complementary bone graft and collagen matrix products

These products address growing clinical needs in bone repair while minimizing the risks and limitations of traditional grafts.

🦴 Altis Biologics is now a leading player in the development of next-generation bone biomaterials, driving a safer, more efficient, and less invasive approach to regenerative medicine.